≡

Insulin Like Growth Factor 1 Receptor (IGF1R)

[Edit]

CD221; IGF1-R; IGFIR; JTK13

Insulin Like Growth Factor 1 Receptor (IGF1R)
CCC B659
HGNC 5465
MGI 96433
PubMed 15499378
RGD 2869
UniProt P08069
Wiki IGF1R

  • The Insulin-like Growth Factor 1 (IGF-1) Receptor is a transmembrane receptor that is activated by IGF-1 and by the related growth factor IGF-2. It belongs to the large class of tyrosine kinase receptors. This receptor mediates the effects of IGF-1, which is a polypeptide protein hormone similar in molecular structure to insulin. IGF-1 plays an important role in growth and continues to have anabolic effects in adults - meaning that it can induce hypertrophy of skeletal muscle and other target tissues. Mice lacking the IGF-1 receptor die late in development, and show a dramatic reduction in body mass, testifying to the strong growth-promoting effect of this receptor. Mice carrying only one functional copy of igf1r are normal, but exhibit a ~15% decrease in body mass.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPB659Hu01 Recombinant Insulin Like Growth Factor 1 Receptor (IGF1R) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAB659Hu01 Polyclonal Antibody to Insulin Like Growth Factor 1 Receptor (IGF1R) WB; IHC; ICC; IP.
MAB659Hu22 Monoclonal Antibody to Insulin Like Growth Factor 1 Receptor (IGF1R) WB; IHC; ICC; IP.
MAB659Hu21 Monoclonal Antibody to Insulin Like Growth Factor 1 Receptor (IGF1R) WB; IHC; ICC; IP.
Assay Kits SEB659Hu ELISA Kit for Insulin Like Growth Factor 1 Receptor (IGF1R) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPB659Mu01 Recombinant Insulin Like Growth Factor 1 Receptor (IGF1R) Positive Control; Immunogen; SDS-PAGE; WB.
RPB659Mu02 Recombinant Insulin Like Growth Factor 1 Receptor (IGF1R) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAB659Mu01 Polyclonal Antibody to Insulin Like Growth Factor 1 Receptor (IGF1R) WB; IHC; ICC; IP.
PAB659Mu02 Polyclonal Antibody to Insulin Like Growth Factor 1 Receptor (IGF1R) WB; IHC; ICC; IP.
Assay Kits SEB659Mu ELISA Kit for Insulin Like Growth Factor 1 Receptor (IGF1R) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPB659Ra01 Recombinant Insulin Like Growth Factor 1 Receptor (IGF1R) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAB659Ra01 Polyclonal Antibody to Insulin Like Growth Factor 1 Receptor (IGF1R) WB; IHC; ICC; IP.
MAB659Ra21 Monoclonal Antibody to Insulin Like Growth Factor 1 Receptor (IGF1R) WB; IHC; ICC; IP.
Assay Kits SEB659Ra ELISA Kit for Insulin Like Growth Factor 1 Receptor (IGF1R) Enzyme-linked immunosorbent assay for Antigen Detection.
  1. "Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity."EMBO J. 5:2503-2512(1986) [PubMed] [Europe PMC] [Abstract]
  2. "Insulin-like growth factor I receptor gene structure."J. Biol. Chem. 267:10759-10763(1992) [PubMed] [Europe PMC] [Abstract]
  3. "Analysis of the DNA sequence and duplication history of human chromosome 15." Nature 440:671-675(2006) [PubMed] [Europe PMC] [Abstract]
  4. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  5. "Analysis of the human type I insulin-like growth factor receptor promoter region."Biochem. Biophys. Res. Commun. 177:1113-1120(1991) [PubMed] [Europe PMC] [Abstract]
  6. "Characterization of human placental insulin-like growth factor-I/insulin hybrid receptors by protein microsequencing and purification."Biochemistry 32:13531-13536(1993) [PubMed] [Europe PMC] [Abstract]
  7. "A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes."Oncogene 8:3403-3410(1993) [PubMed] [Europe PMC] [Abstract]
  8. "Interaction of the alpha beta dimers of the insulin-like growth factor I receptor is required for receptor autophosphorylation."Biochemistry 30:48-54(1991) [PubMed] [Europe PMC] [Abstract]
  9. "Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity."Biochem. J. 290:419-426(1993) [PubMed] [Europe PMC] [Abstract]
  10. "Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3)."J. Biol. Chem. 268:2655-2661(1993) [PubMed] [Europe PMC] [Abstract]
  11. "Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor."J. Biol. Chem. 270:15639-15643(1995) [PubMed] [Europe PMC] [Abstract]
  12. "Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting."Biochem. J. 327:209-215(1997) [PubMed] [Europe PMC] [Abstract]
  13. "14-3-3 proteins interact with the insulin-like growth factor receptor but not the insulin receptor."Biochem. J. 327:765-771(1997) [PubMed] [Europe PMC] [Abstract]
  14. "Distribution of insulin/insulin-like growth factor-I hybrid receptors in human tissues."Mol. Cell. Endocrinol. 129:121-126(1997) [PubMed] [Europe PMC] [Abstract]
  15. "Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor."J. Biol. Chem. 273:24095-24101(1998) [PubMed] [Europe PMC] [Abstract]
  16. "beta-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor."J. Biol. Chem. 273:31640-31643(1998) [PubMed] [Europe PMC] [Abstract]
  17. "The IGF-I receptor in cancer research."Exp. Cell Res. 253:1-6(1999) [PubMed] [Europe PMC] [Abstract]
  18. "Grb10, a positive, stimulatory signaling adapter in platelet-derived growth factor BB-, insulin-like growth factor I-, and insulin-mediated mitogenesis."Mol. Cell. Biol. 19:6217-6228(1999) [PubMed] [Europe PMC] [Abstract]
  19. "Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor."Biochem. Biophys. Res. Commun. 278:38-43(2000) [PubMed] [Europe PMC] [Abstract]
  20. "Autophosphorylation of the insulin-like growth factor I receptor cytoplasmic domain."Biochem. Biophys. Res. Commun. 279:955-960(2000) [PubMed] [Europe PMC] [Abstract]
  21. "Mechanism of STAT3 activation by insulin-like growth factor I receptor."J. Biol. Chem. 275:15099-15105(2000) [PubMed] [Europe PMC] [Abstract]
  22. "Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease."Cancer Res. 62:2942-2950(2002) [PubMed] [Europe PMC] [Abstract]
  23. "Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved."J. Biol. Chem. 277:39684-39695(2002) [PubMed] [Europe PMC] [Abstract]
  24. "RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix."Mol. Cell. Biol. 22:2345-2365(2002) [PubMed] [Europe PMC] [Abstract]
  25. "Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1)."J. Biol. Chem. 278:13325-13332(2003) [PubMed] [Europe PMC] [Abstract]
  26. "Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor."Proc. Natl. Acad. Sci. U.S.A. 100:8247-8252(2003) [PubMed] [Europe PMC] [Abstract]
  27. "Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth."Cancer Res. 64:236-242(2004) [PubMed] [Europe PMC] [Abstract]
  28. "{beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase."J. Biol. Chem. 280:24412-24419(2005) [PubMed] [Europe PMC] [Abstract]
  29. "JAK/STAT3 pathway is involved in survival of neurons in response to insulin-like growth factor and negatively regulated by suppressor of cytokine signaling-3."J. Biol. Chem. 280:31830-31840(2005) [PubMed] [Europe PMC] [Abstract]
  30. "Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant."J. Biol. Chem. 281:25869-25874(2006) [PubMed] [Europe PMC] [Abstract]
  31. "The insulin-like growth factor 1 (IGF-1) receptor is a substrate for gamma-secretase-mediated intramembrane proteolysis."Biochem. Biophys. Res. Commun. 358:1136-1141(2007) [PubMed] [Europe PMC] [Abstract]
  32. "The insulin-like growth factor 1 receptor in cancer: old focus, new future."Eur. J. Cancer 43:1895-1904(2007) [PubMed] [Europe PMC] [Abstract]
  33. "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract]
  34. "Large-scale proteomics analysis of the human kinome."Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract]
  35. "Development and validation of a method for profiling post-translational modification activities using protein microarrays."PLoS ONE 5:E11332-E11332(2010) [PubMed] [Europe PMC] [Abstract]
  36. "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
  37. "Polyubiquitination of insulin-like growth factor I receptor (IGF-IR) activation loop promotes antibody-induced receptor internalization and down-regulation."J. Biol. Chem. 286:41852-41861(2011) [PubMed] [Europe PMC] [Abstract]
  38. "Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor."Nature 394:395-399(1998) [PubMed] [Europe PMC] [Abstract]
  39. "Structure and autoregulation of the insulin-like growth factor 1 receptor kinase."Nat. Struct. Biol. 8:1058-1063(2001) [PubMed] [Europe PMC] [Abstract]
  40. "Crystal structure of bisphosphorylated IGF-1 receptor kinase: insight into domain movements upon kinase activation."Structure 9:955-965(2001) [PubMed] [Europe PMC] [Abstract]
  41. "Crystal structure of the Apo, unactivated insulin-like growth factor-1 receptor kinase. Implication for inhibitor specificity."J. Biol. Chem. 277:38797-38802(2002) [PubMed] [Europe PMC] [Abstract]
  42. "Structure of apo, unactivated insulin-like growth factor-1 receptor kinase at 1.5 A resolution."Acta Crystallogr. D 59:1725-1730(2003) [PubMed] [Europe PMC] [Abstract]
  43. "Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R)."Bioorg. Med. Chem. Lett. 17:2317-2321(2007) [PubMed] [Europe PMC] [Abstract]
  44. "Lead identification to generate isoquinolinedione inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment."Bioorg. Med. Chem. Lett. 18:3641-3645(2008) [PubMed] [Europe PMC] [Abstract]
  45. "Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor."EMBO J. 27:1985-1994(2008) [PubMed] [Europe PMC] [Abstract]
  46. "Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment."Bioorg. Med. Chem. Lett. 19:62-66(2009) [PubMed] [Europe PMC] [Abstract]
  47. "Discovery of a 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitor (BMS-754807) of insulin-like growth factor receptor (IGF-1R) kinase in clinical development." J. Med. Chem. 52:7360-7363(2009) [PubMed] [Europe PMC] [Abstract]
  48. "Allosteric IGF-1R Inhibitors."ACS Med. Chem. Lett. 1:199-203(2010)
  49. "Proline isosteres in a series of 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitors of IGF-1R kinase and IR kinase."Bioorg. Med. Chem. Lett. 20:5027-5030(2010) [PubMed] [Europe PMC] [Abstract]
  50. "Design of potent IGF1-R inhibitors related to bis-azaindoles."Chem. Biol. Drug Des. 76:100-106(2010) [PubMed] [Europe PMC] [Abstract]
  51. "Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: advantages in comparison with competitive inhibitors."Bioorg. Med. Chem. Lett. 21:2224-2228(2011) [PubMed] [Europe PMC] [Abstract]
  52. "Discovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitors." Bioorg. Med. Chem. Lett. 21:2394-2399(2011) [PubMed] [Europe PMC] [Abstract]
  53. "IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation."N. Engl. J. Med. 349:2211-2222(2003) [PubMed] [Europe PMC] [Abstract]
  54. "Mutation at cleavage site of insulin-like growth factor receptor in a short-stature child born with intrauterine growth retardation."J. Clin. Endocrinol. Metab. 90:4679-4687(2005) [PubMed] [Europe PMC] [Abstract]
  55. "Patterns of somatic mutation in human cancer genomes." Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract]